Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients (EP8SH)

  • STATUS
    Recruiting
  • participants needed
    46
  • sponsor
    Centre Hospitalier Universitaire, Amiens
Send
Updated on 24 November 2021
See if I qualify

Summary

Determination of the hemodialysis ultrafiltration volume is guided by the clinician's estimate of dry weight. A poor estimate of this dry weight may result in insufficient fluid depletion causing a state of volume overload, which may be associated with long-term left ventricular failure, high blood pressure and excess of mortality. The diagnosis of fluid overload in haemodialysis patient is routinely based on clinical examination which consists of cardiopulmonary auscultation and edema palpation of limb member. Clinical examination can be completed by paraclinical examinations, and bioimpedance is an objective tool that assess fluid overload state. This test provides an individualized hydration status and fluid overload based on normal extracellular volume considering body composition. Echocardiography allows an accurate assessment of blood volume status by simultaneous studying left ventricular filling pressures, systolic pulmonary artery pressure and the diameter of the inferior vena cava. Lung ultrasound analyses the B-lines defined as artefactual images resulting from contact between air in "alveoli" and water in "septa". It can estimate pulmonary congestion. The aim of the study is to evaluate the lung ultrasound using "8 sites" score accuracy for estimating fluid overload of patients before hemodialysis session.

Details
Condition Lung Ultrasound, Hemodialysis Complication
Age 18years or above
Treatment lung ultrasound
Clinical Study IdentifierNCT05132036
SponsorCentre Hospitalier Universitaire, Amiens
Last Modified on24 November 2021

Eligibility

 Yes No Not Sure

Inclusion Criteria

Age over 18 years old
patients on hemodialysis for more than 3 months
patients without cardiological or infectious event for at least 3 months
patients having at least 2 dialysis session per week
patients affiliated with a health insurance plan
patients having signed an informed consent

Exclusion Criteria

Pulmonary fibrosis or active lung disease
residual diuresis over 500 mL per day
body mass index (BMI) < 21 and > 28 Kg/m²
medical history of major amputation (subgonal or transfemoral)
pacemaker carrier
patients with orthopedic prosthesis
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.